Compare Onto Innovation (ONTO) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Onto Innovation vs State Street SPDR S&P Biotech ETF — how do they compare? Onto Innovation trades at $294.53 (market cap $14.36B), while State Street SPDR S&P Biotech ETF trades at $153.75 (market cap $10.11B). The key difference: Onto Innovation is the larger of the two by market cap, and Onto Innovation is more actively traded (761,617 versus 12,903,266). Which is the better fit depends on your goals — on Pluang, investors hold Onto Innovation for 6 Days and State Street SPDR S&P Biotech ETF for 38 Days on average.
| ONTO | XBI | |
|---|---|---|
Market Cap | $14.36B | $10.11B |
Volume | 761,617 | 12,903,266 |
Sector | Technology | Broad Market / Factor |
52-Week High | $378.45 | $169.55 |
52-Week Low | $121.34 | $104.99 |
Typical Hold Time | 6 Days | 38 Days |
Enterprise Value | $13.95B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XBI trades at $149.29, down 0.63% on the day, with technical indicators showing a bearish bias despite an oversold RSI reading. The ETF faces mixed sentiment with 100% hold ratings from analysts but positive news flow around biotech catalysts. Recent articles highlight XBI's biotech focus versus broader healthcare ETFs, with expense ratio comparisons and volatility considerations.
The outlook remains cautious due to technical weakness and high volatility, though sector-specific catalysts like cancer vaccine developments and M&A activity provide potential upside. Key risks include sector volatility, regulatory uncertainty, and competitive ETF offerings with lower fees.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Onto Innovation
Onto Innovation provides process control solutions for semiconductor manufacturing. Its inspection and metrology systems help chipmakers measure, analyze, and detect defects on wafers and advanced packages.
Read more on ONTO →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
